| |
| |
|
| Insider
Information: |
Sirgo Mark A |
| Relationship: |
Director |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,587,828 |
|
|
Indirect Shares
|
22,965 |
|
|
| Direct
Value |
$16,116 |
|
|
|
Indirect Value
|
$8,273 |
|
|
| Total
Shares |
1,610,793 |
|
|
| Total
Value |
$24,389 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
18
|
5
|
|
Stock
price went up :
|
11
|
1
|
| Stock
price went down : |
7
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
1.6
|
1.6
|
| Percentage
Gain/Loss : |
 21.7%
|
 -32.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biodelivery Sciences Internation... |
BDSI |
Director |
2022-03-22 |
0 |
2014-09-04 |
1,480 |
Premium* |
|
|
Salix Pharmaceuticals Ltd |
SLXP |
Director |
2015-04-01 |
0 |
2008-07-01 |
0 |
Premium* |
|
|
Biomerica Inc |
BMRA |
Director |
2020-04-21 |
27,400 |
2016-08-01 |
0 |
Premium* |
|
|
9 Meters Biopharma Inc |
NMTR |
Director |
2022-07-01 |
1,560,428 |
2022-07-01 |
21,485 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
182 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BDSI |
Biodelivery Sciences Inte... |
Chief Executive Officer |
• • – |
2005-09-30 |
4 |
B |
$1.88 |
$28,747 |
D/D |
13,800 |
19,800 |
2.81 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Chief Financial Officer |
• • – |
2005-08-12 |
5 |
B |
$2.60 |
$1,300 |
D/D |
500 |
20,300 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Chief Financial Officer |
• • – |
2005-08-23 |
5 |
B |
$2.54 |
$508 |
D/D |
200 |
20,300 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Chief Financial Officer |
• • – |
2005-08-29 |
5 |
B |
$2.69 |
$269 |
D/D |
100 |
20,300 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Chief Financial Officer |
• • – |
2005-09-01 |
5 |
B |
$2.55 |
$5,136 |
D/D |
2,000 |
20,300 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2008-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,676 |
27,676 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-02-02 |
4 |
D |
$8.00 |
$12,000 |
D/D |
(1,500) |
26,176 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-02-02 |
4/A |
D |
$8.00 |
$12,400 |
D/D |
(1,550) |
26,126 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-05-08 |
4 |
B |
$10.34 |
$10,385 |
D/D |
1,000 |
27,126 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-07-01 |
4 |
D |
$9.87 |
$38,789 |
D/D |
(3,930) |
23,196 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,160 |
35,356 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-08-14 |
4 |
B |
$12.40 |
$11,840 |
D/D |
950 |
36,306 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-01-06 |
4 |
B |
$27.89 |
$5,578 |
D/D |
200 |
36,506 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-01-15 |
4 |
B |
$27.09 |
$5,418 |
D/D |
200 |
36,706 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-02-04 |
4 |
D |
$29.26 |
$45,353 |
D/D |
(1,550) |
35,156 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-07-01 |
4 |
D |
$39.03 |
$147,143 |
D/D |
(3,770) |
31,386 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,360 |
35,746 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-03-10 |
4 |
S |
$32.40 |
$54,270 |
D/D |
(1,675) |
34,071 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,640 |
38,711 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-05-27 |
4 |
S |
$38.93 |
$65,208 |
D/D |
(1,675) |
37,036 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-07-01 |
4 |
D |
$39.83 |
$53,850 |
D/D |
(1,352) |
35,684 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,160 |
38,405 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-11-12 |
4 |
S |
$40.30 |
$69,518 |
D/D |
(1,725) |
36,680 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-11-13 |
4 |
S |
$40.75 |
$70,294 |
D/D |
(1,725) |
34,955 |
0 |
- |
|
182 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
